These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18189424)

  • 1. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
    Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
    Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase.
    Chatterjee C; Young EK; Pussegoda KA; Twomey EE; Pandey NR; Sparks DL
    Biochemistry; 2009 Jun; 48(25):5994-6001. PubMed ID: 19425605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion.
    Hopewell S; Pandey NR; Misquith A; Twomey E; Sparks DL
    Metabolism; 2008 Dec; 57(12):1677-84. PubMed ID: 19013290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipids as cardiovascular therapeutics.
    Pandey NR; Sparks DL
    Curr Opin Investig Drugs; 2008 Mar; 9(3):281-5. PubMed ID: 18311664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
    Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
    Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
    Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
    Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S; Liu T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic peroxisome proliferator-activated receptor alpha expression but not adiponectin by dietary protein in finishing pigs.
    Weber TE; Kerr BJ; Spurlock ME
    J Anim Physiol Anim Nutr (Berl); 2008 Oct; 92(5):569-77. PubMed ID: 19012601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
    Nagasawa M; Hara T; Kashino A; Akasaka Y; Ide T; Murakami K
    Biochem Pharmacol; 2009 Sep; 78(5):523-30. PubMed ID: 19433068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An induction in hepatic HDL secretion associated with reduced ATPase expression.
    Pandey NR; Renwick J; Rabaa S; Misquith A; Kouri L; Twomey E; Sparks DL
    Am J Pathol; 2009 Oct; 175(4):1777-87. PubMed ID: 19717637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
    Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
    Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
    Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
    van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
    Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
    J Cell Biochem; 2019 Oct; 120(10):17219-17227. PubMed ID: 31106471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein.
    Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C
    Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.
    Chatterjee C; Sparks DL
    PLoS One; 2012; 7(5):e36916. PubMed ID: 22590634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.